Form 4: SelectQuote Executive Granted Restricted Stock Units and Price-Vested Restricted Stock Units

Robert Clay Grant, President of SelectQuote, Inc., was granted restricted stock units and price-vested restricted stock units on October 28, 2024, under the company's 2020 Omnibus Incentive Plan.

Summary

• On October 28, 2024, Robert Clay Grant, President of SelectQuote, Inc., received grants of restricted stock units (RSUs) and price-vested restricted stock units (PVUs) under the company's 2020 Omnibus Incentive Plan.
• A total of 367,412 RSUs were granted, each representing a contingent right to receive one share of SelectQuote's common stock.
• These RSUs vest ratably in three annual installments starting August 1, 2025, contingent upon continued employment.
• An additional 367,412 PVUs were granted, also representing a contingent right to receive one share of common stock upon the company's stock reaching certain price targets.
• The PVUs are also eligible to vest in three annual installments commencing August 1, 2025, subject to continued employment.
• Vesting of the PVUs is contingent on the 60-day average closing price of SelectQuote's common stock exceeding $3.13, $6.00, and $9.00 during a five-year performance period.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, suggesting a positive outlook on incentivizing management. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs and PVUs aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.
• The vesting schedules, contingent on continued employment and stock price performance, encourage retention and focus on achieving company goals.

Risks

• The value of the RSUs and PVUs is dependent on the future performance of SelectQuote's stock price, which is subject to market fluctuations and company-specific risks.
• If the stock price does not reach the specified targets, the PVUs may not vest, potentially impacting the executive's compensation.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted equity.

Industry Context

Equity compensation is a common practice in publicly traded companies to incentivize executives and align their interests with those of shareholders. The specific terms of the grant, such as vesting schedules and performance targets, are tailored to the company's specific circumstances and goals.

Comparison to Industry Standards

• Comparing SelectQuote's equity compensation practices to those of its competitors, such as eHealth, Inc. (EHTH) or GoHealth (GOCO), would provide a benchmark for assessing the competitiveness and appropriateness of the grants.
• Industry standards for vesting schedules typically range from three to five years, with performance-based vesting becoming increasingly common.
• The specific price targets for the PVUs should be evaluated in the context of SelectQuote's historical stock performance and future growth prospects.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning management's interests with long-term value creation.
• Employees may be motivated by the potential for future stock price appreciation, contributing to a positive work environment.

Key Dates